File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Noninvasive imaging evaluation of peritoneal recurrence and chemotherapy benefit in gastric cancer after gastrectomy: a multicenter study.

TitleNoninvasive imaging evaluation of peritoneal recurrence and chemotherapy benefit in gastric cancer after gastrectomy: a multicenter study.
Authors
Issue Date1-Jul-2023
PublisherElsevier
Citation
International journal of surgery (London, England), 2023, v. 109, n. 7, p. 2010-2024 How to Cite?
AbstractBACKGROUND\nMETHODS\nRESULTS\nCONCLUSION\nPeritoneal recurrence (PR) is the predominant pattern of relapse after curative-intent surgery in gastric cancer (GC) and indicates a dismal prognosis. Accurate prediction of PR is crucial for patient management and treatment. The authors aimed to develop a noninvasive imaging biomarker from computed tomography (CT) for PR evaluation, and investigate its associations with prognosis and chemotherapy benefit.\nIn this multicenter study including five independent cohorts of 2005 GC patients, the authors extracted 584 quantitative features from the intratumoral and peritumoral regions on contrast-enhanced CT images. The artificial intelligence algorithms were used to select significant PR-related features, and then integrated into a radiomic imaging signature. And improvements of diagnostic accuracy for PR by clinicians with the signature assistance were quantified. Using Shapley values, the authors determined the most relevant features and provided explanations to prediction. The authors further evaluated its predictive performance in prognosis and chemotherapy response.\nThe developed radiomics signature had a consistently high accuracy in predicting PR in the training cohort (area under the curve: 0.732) and internal and Sun Yat-sen University Cancer Center validation cohorts (0.721 and 0.728). The radiomics signature was the most important feature in Shapley interpretation. The diagnostic accuracy of PR with the radiomics signature assistance was improved by 10.13-18.86% for clinicians ( P <0.001). Furthermore, it was also applicable in the survival prediction. In multivariable analysis, the radiomics signature remained an independent predictor for PR and prognosis ( P <0.001 for all). Importantly, patients with predicting high risk of PR from radiomics signature could gain survival benefit from adjuvant chemotherapy. By contrast, chemotherapy had no impact on survival for patients with a predicted low risk of PR.\nThe noninvasive and explainable model developed from preoperative CT images could accurately predict PR and chemotherapy benefit in patients with GC, which will allow the optimization of individual decision-making.
Persistent Identifierhttp://hdl.handle.net/10722/331452
ISSN
2023 Impact Factor: 12.5
2023 SCImago Journal Rankings: 2.895
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorSun, Z-
dc.contributor.authorWang, W-
dc.contributor.authorHuang, W-
dc.contributor.authorZhang, T-
dc.contributor.authorChen, C-
dc.contributor.authorYuan, Q-
dc.contributor.authorChen, Y-
dc.contributor.authorZhou, K-
dc.contributor.authorHan, Z-
dc.contributor.authorFeng, H-
dc.contributor.authorChen, H-
dc.contributor.authorLiang, X-
dc.contributor.authorHu, Y-
dc.contributor.authorYu, J-
dc.contributor.authorLiu, H-
dc.contributor.authorYu, L-
dc.contributor.authorXu, Y-
dc.contributor.authorLi, G-
dc.contributor.authorJiang, Y-
dc.date.accessioned2023-09-21T06:55:52Z-
dc.date.available2023-09-21T06:55:52Z-
dc.date.issued2023-07-01-
dc.identifier.citationInternational journal of surgery (London, England), 2023, v. 109, n. 7, p. 2010-2024-
dc.identifier.issn1743-9191-
dc.identifier.urihttp://hdl.handle.net/10722/331452-
dc.description.abstractBACKGROUND\nMETHODS\nRESULTS\nCONCLUSION\nPeritoneal recurrence (PR) is the predominant pattern of relapse after curative-intent surgery in gastric cancer (GC) and indicates a dismal prognosis. Accurate prediction of PR is crucial for patient management and treatment. The authors aimed to develop a noninvasive imaging biomarker from computed tomography (CT) for PR evaluation, and investigate its associations with prognosis and chemotherapy benefit.\nIn this multicenter study including five independent cohorts of 2005 GC patients, the authors extracted 584 quantitative features from the intratumoral and peritumoral regions on contrast-enhanced CT images. The artificial intelligence algorithms were used to select significant PR-related features, and then integrated into a radiomic imaging signature. And improvements of diagnostic accuracy for PR by clinicians with the signature assistance were quantified. Using Shapley values, the authors determined the most relevant features and provided explanations to prediction. The authors further evaluated its predictive performance in prognosis and chemotherapy response.\nThe developed radiomics signature had a consistently high accuracy in predicting PR in the training cohort (area under the curve: 0.732) and internal and Sun Yat-sen University Cancer Center validation cohorts (0.721 and 0.728). The radiomics signature was the most important feature in Shapley interpretation. The diagnostic accuracy of PR with the radiomics signature assistance was improved by 10.13-18.86% for clinicians ( P <0.001). Furthermore, it was also applicable in the survival prediction. In multivariable analysis, the radiomics signature remained an independent predictor for PR and prognosis ( P <0.001 for all). Importantly, patients with predicting high risk of PR from radiomics signature could gain survival benefit from adjuvant chemotherapy. By contrast, chemotherapy had no impact on survival for patients with a predicted low risk of PR.\nThe noninvasive and explainable model developed from preoperative CT images could accurately predict PR and chemotherapy benefit in patients with GC, which will allow the optimization of individual decision-making.-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofInternational journal of surgery (London, England)-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleNoninvasive imaging evaluation of peritoneal recurrence and chemotherapy benefit in gastric cancer after gastrectomy: a multicenter study.-
dc.typeArticle-
dc.identifier.doi10.1097/JS9.0000000000000328-
dc.identifier.pmid37300884-
dc.identifier.scopuseid_2-s2.0-85165546396-
dc.identifier.volume109-
dc.identifier.issue7-
dc.identifier.spage2010-
dc.identifier.epage2024-
dc.identifier.eissn1743-9159-
dc.identifier.isiWOS:001035761700020-
dc.identifier.issnl1743-9159-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats